Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced financial and operating results for the first quarter ended March 31, 2014, and other business updates.
Key financial highlights include:
•First quarter 2014 results include the impact of the Santarus acquisition, which was completed on January 2, 2014.
Help employers find you! Check out all the jobs and post your resume.
